The most active researchers, institutions, and subtopics in Rheumatoid Arthritis, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 600 recent PubMed papers (2021-2026) matching "rheumatoid arthritis JAK inhibitor biologic". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Tanaka Yoshiya | University of Occupational and Environmental Health | 23 |
| 2 | Takeuchi Tsutomu | Keio University School of Medicine | 16 |
| 3 | Hashimoto Motomu | Osaka Metropolitan University Graduate School of Medicine | 16 |
| 4 | Yamamoto Wataru | Kurashiki Sweet Hospital | 15 |
| 5 | Son Yonsu | Kansai Medical University | 14 |
| 6 | Onishi Akira | Kyoto University | 13 |
| 7 | Finckh Axel | Geneva University Hospitals | 12 |
| 8 | Murata Koichi | Kyoto University | 12 |
| 9 | Amuro Hideki | Kansai Medical University | 12 |
| 10 | Hara Ryota | Nara Medical University | 12 |
| 11 | Kaneko Yuko | Keio University School of Medicine | 11 |
| 12 | Okano Tadashi | Osaka Metropolitan University Graduate School of Medicine | 11 |
| 13 | Ebina Kosuke | Osaka University Graduate School of Medicine | 11 |
| 14 | Hayashi Shinya | Kobe University Graduate School of Medicine | 11 |
| 15 | Askling Johan | Clinical Epidemiology Division | 11 |
| 16 | Strangfeld Anja | Germany; Department of Rheumatology and Clinical Immunolog | 11 |
| 17 | Katayama Masaki | Osaka Red Cross Hospital | 10 |
| 18 | Sung Yoon-Kyoung | Hanyang University Hospital for Rheumatic Diseases | 9 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
IL-7-glucose-Aiolos axis orchestrates pathogenic CD8 (2026) · PMID 42461767
Recent Knowledge Regarding the Epidemiology, Exacerbating Factors, and Treatment of Rheumatoid Arthritis Complicated by Interstiti (2026) · PMID 42452635
Sex Differences in Treatment Response to Targeted Therapy in Rheumatoid Arthritis: A Post Hoc Analysis of a Prospective Observatio (2026) · PMID 42444380
Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a (2026) · PMID 42440279
Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthet (2026) · PMID 42429076
A full Rheumatoid Arthritis brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.